In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

Outer membrane protein TraT protects bacteria from secondary F plasmid conjugation. Here, the authors report cryo-EM structure of decameric cork-like TraT and its evolutionary history as a ...

Aspiring participants of the GATE 2025 Biotechnology (BT) exam must go through the syllabus of Biotechnology (BT). The ...

Regarding the article "Critics Sharpen Assault On Peer Review" by Paul McCarthy (The Scientist, May 30, 1994, page 1): While peer review is certainly not perfect, those of us who depend on it are well ...

Credit: Courtesy of GE" /> Credit: Courtesy of GE ON YOUR MARK, GET SET, GE! >> The Summer Olympics, in Beijing will feature world-class athletes and the subject of our profile GE. The company has ...

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR ...